Cargando…
Engineered endolysin-based “artilysins” for controlling the gram-negative pathogen Helicobacter pylori
Helicobacter pylori infection can cause a variety of gastrointestinal diseases. In severe cases, there is a risk of gastric cancer. Antibiotics are often used for clinical treatment of H. pylori infections. However, because of antibiotic overuse in recent years and the emergence of multidrug-resista...
Autores principales: | Xu, Dengyuan, Zhao, Shanshan, Dou, Jun, Xu, Xiaofeng, Zhi, Yanyan, Wen, Liangzhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081812/ https://www.ncbi.nlm.nih.gov/pubmed/33913058 http://dx.doi.org/10.1186/s13568-021-01222-8 |
Ejemplares similares
-
Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens
por: Briers, Yves, et al.
Publicado: (2014) -
Characterization and Engineering Studies of a New Endolysin from the Propionibacterium acnes Bacteriophage PAC1 for the Development of a Broad-Spectrum Artilysin with Altered Specificity
por: Varotsou, Christina, et al.
Publicado: (2023) -
Bactericidal Effect of Cecropin A Fused Endolysin on Drug-Resistant Gram-Negative Pathogens
por: Lim, Jeonghyun, et al.
Publicado: (2022) -
Discovering the Potentials of Four Phage Endolysins to Combat Gram-Negative Infections
por: Vasina, Daria V., et al.
Publicado: (2021) -
Current Status of Endolysin-Based Treatments against Gram-Negative Bacteria
por: Gontijo, Marco Túlio Pardini, et al.
Publicado: (2021)